MEF2B | bioCADDIE Data Discovery Index
Mountain View
biomedical and healthCAre Data Discovery Index Ecosystem
help Advanced Search
Displaying 20 of 50 results for "MEF2B"
i
  1. The MEF2B Regulatory Network - MEF2B-V5 ChIP-seq data ArrayExpress

    ID: E-GEOD-67450

    Description: Myocyte enhancer factor 2B (MEF2B) is a transcription <...

  2. The MEF2B Regulatory Network - MEF2B-V5 ChIP-seq data BioProject

    ID: PRJNA279977

    Keywords: Epigenomics

    Access Type: download

  3. The MEF2B Regulatory Network - H3K27ac and H3K4me3 ChIP-seq data ArrayExpress

    ID: E-GEOD-67455

    Description: Myocyte enhancer factor 2B (MEF2B) is a transcription <...

  4. The MEF2B Regulatory Network - Expression microarray data BioProject

    ID: PRJNA279862

    Keywords: Transcriptome or Gene expression

    Access Type: download

  5. The MEF2B Regulatory Network - Expression microarray data ArrayExpress

    ID: E-GEOD-67417

    Description: Myocyte enhancer factor 2B (MEF2B) is a transcription <...

  6. The MEF2B Regulatory Network - H3K27ac and H3K4me3 ChIP-seq data BioProject

    ID: PRJNA279985

    Keywords: Epigenomics

    Access Type: download

  7. The MEF2B Regulatory Network - RNA-seq data ArrayExpress

    ID: E-GEOD-67447

    Description: Myocyte enhancer factor 2B (MEF2B) is a transcription <...

  8. The MEF2B Regulatory Network - RNA-seq data BioProject

    ID: PRJNA279975

    Keywords: Transcriptome or Gene expression

    Access Type: download

  9. Structural basis of sequence-specific recruitment of histone deacetylases by Myocyte Enhancer Factor-2 PDB

    ID: PDB:1N6J

    Description: Myocyte-specific enhancer factor 2B/Calcineurin-binding protein Cabin 1/DN...

  10. The MEF2B Regulatory Network - RNA-seq data OmicsDI

    ID: E-GEOD-67447

    Date Released: 08-19-2015

    Description: Myocyte enhancer factor 2B (MEF2B) is a transcription <...

  11. The MEF2B Regulatory Network - Expression microarray data OmicsDI

    ID: E-GEOD-67417

    Date Released: 08-19-2015

    Description: Myocyte enhancer factor 2B (MEF2B) is a transcription <...

  12. The MEF2B Regulatory Network - MEF2B-V5 ChIP-seq data OmicsDI

    ID: E-GEOD-67450

    Date Released: 08-19-2015

    Description: Myocyte enhancer factor 2B (MEF2B) is a transcription <...

  13. The MEF2B Regulatory Network - H3K27ac and H3K4me3 ChIP-seq data OmicsDI

    ID: E-GEOD-67455

    Date Released: 08-19-2015

    Description: Myocyte enhancer factor 2B (MEF2B) is a transcription <...

  14. Mechanism of recruitment of class II histone deacetylases by myocyte enhancer factor-2 PDB

    ID: PDB:1TQE

    Description: MEF2 binding site of nur77 promoter/Myocyte-specific enhancer factor 2B/DNA Complex...

  15. Identification of MEF2B, EBF1, and IL6R as chromosome bound targets of EBNA1 essential for EBV infected B-lymphocyte survival BioProject

    ID: PRJNA298334

    Keywords: Other

    Access Type: download

  16. Identification of MEF2B, EBF1, and IL6R as chromosome bound targets of EBNA1 essential for EBV infected B-lymphocyte survival OmicsDI

    ID: E-GEOD-73887

    Date Released: 12-19-2015

    Description: Seq and RNA-Seq with experimental validation that MEF2B, IL6R, and EBF1 are high confidence target genes of EBNA1 that are essential for viability of B-lymphocytes latently infected with EBV. We show that EBNA1 binds to ~1000 sites with many, but not all, universally bound in different cell types, including Burkitt lymphoma (BL) and nasopharyngeal carcinoma (NPC). We find that a large subset of EBNA1 binding sites are located proximal to transcription start sites and correlate genome-wide with transcription activity. EBNA1 bound to genes of high significance for B-cell growth and function, including MEF2B, IL6R, EBF1, RNF145, POU2F1, KDM4C, FGR, EGFR, LAIR, CDC7, CD44, and IL17A. EBNA1 depletion from latently infect...

  17. Identification of MEF2B, EBF1, and IL6R as chromosome bound targets of EBNA1 essential for EBV infected B-lymphocyte survival ArrayExpress

    ID: E-GEOD-73887

    Description: Seq and RNA-Seq with experimental validation that MEF2B, IL6R, and EBF1 are high confidence target genes of EBNA1 that are essential for viability of B-lymphocytes latently infected with EBV. We show that EBNA1 binds to ~1000 sites with many, but not all, universally bound in different cell types, including Burkitt lymphoma (BL) and nasopharyngeal carcinoma (NPC). We find that a large subset of EBNA1 binding sites are located proximal to transcription start sites and correlate genome-wide with transcription activity. EBNA1 bound to genes of high significance for B-cell growth and function, including MEF2B, IL6R, EBF1, RNF145, POU2F1, KDM4C, FGR, EGFR, LAIR, CDC7, CD44, and IL17A. EBNA1 depletion from latently infect...

  18. Pediatric-type Follicular Lymphoma : Ion Torrent NGS Analysis of pediatric-type Follicular Lymphoma BioProject

    ID: PRJEB12904

    Keywords: Other

    Access Type: download

    dataset.description: s included CREBBP, KMT2D, TNFRSF14, GNA13, FOXO1, MEF2B, HIST1H1B-E, EZH2 and EP300....
  19. Dynamic changes in E protein activity orchestrate germinal center and plasma cell development [RNA-Seq] ArrayExpress

    ID: E-GEOD-72831

    Description: d B cell differentiation, including Blimp1, Xbp1, Mef2b and CXCR4 and is therefore critical for establishing the transcriptional network that controls GC B cell and plasma cell differentiation. Transcriptional profiling of wild type, Id3 knockout and E2A/E22 double knockout B cells using RNA sequencing...

  20. Genetic Heterogeneity of DLBCL ArrayExpress

    ID: E-GEOD-43606

    Description: ose related to chromatin modification (ARID1A and MEF2B), NF-κB (CARD11 and TNFAIP3), PI3 kinase (PIK3CD, PIK3R1, and MTOR), B-cell lineage (IRF8, POU2F2, and GNA13), and WNT signaling (WIF1). We also experimentally validated a mutation in PIK3CD, a gene not previously implicated in lymphomas. The patterns of mutation demonstrated a classic long tail distribution with substantial variation of mutated genes from patient to patient and also between published studies. Thus, our study reveals the tremendous genetic heterogeneity that underlies lymphomas and highlights the need for personalized medicine approaches to treating these patients. 21 DLBCL cell lines and 70 DLBCL patient samples....


Displaying 20 of 50 results for "MEF2B"